Primary antibody binding to antigens was detected with an affinity-purified, peroxidase-conjugated donkey anti-chicken IgY (Jackson Immunoresearch Laboratories, Inc., West Grove, PA, USA) at a dilution of 1 5,000.
MGL on dendritic cells binding to Tn antigen is associated with antigen presentation and regulation of activation of immune cells (Denda-Nagai et al. 2010; Singh et al. 2011; Napoletano et al. 2012).
Two different radiolabeled forms of the same mAb were injected into groups of LNCaP tumor-bearing mice and their tumor uptake kinetics compared by serial PET imaging: J591, a specific PSMA-targeted antibody that is known to be internalized after binding to extracellular antigen, labeled with either 89Zr, a residualizing PET isotope, or 124I, a non-residualizing PET isotope.
Competition with or pre-absorption of the antibody with excess peptide controls for the antigen, demonstrating that localization of the antibody is consistent with binding to that antigen.
To confirm that the cell surface-anchored PS11-scFvFc remains functional for binding to its antigen, 293T cells transfected with different PS11-scFvFc-TM fusion proteins were stained with a biotinylated-TRM peptide and analyzed by FACS, using APC-conjugated streptavidin.
A tumor-state signature may include autoantibodies binding to self-antigens not necessarily associated with the specific tumor.
SPR analysis demonstrated that the trimerbody had a higher binding signal than the monomeric antibody and apparently slower dissociation, consistent with multivalent binding to the antigen.
The relative affinities of mAbs binding to respective coated antigens were determined with ELISA by measuring the concentration of each mAb required to achieve 50% maximal binding at saturation (K50).
Infected cell protein 47 (inhibitsnhibits MHC Ⅰ antigen presentation pathway by binding to host transporter associated with antigen presentation (TAP), and thereby attenuates of specific cytotoxic T lymphocytes (CTLs) responses and evades the host immune clearance.
This class of antibodies establishes a transient synapse between T cells and cancer cells by binding to a surface antigen on cancer cells with one arm and simultaneously recruiting T cells via the CD3 domain, which is the signal transmitting portion of the T-cell receptor complex.
